ReviewCancer control : journal of the Moffitt Cancer Center

Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma.

Renba Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.